Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RD

Ryan Dellinger — 18 Patents

CHChromadex: 8 patents #7 of 22Top 35%
EHElysium Health: 8 patents #2 of 13Top 20%
QBQueens University Of Belfast: 3 patents #32 of 232Top 15%
University of California: 3 patents #2,984 of 18,278Top 20%
UGUniversitat De Valencia-Estudi General: 2 patents #2 of 41Top 5%
Azusa, CA: #6 of 122 inventorsTop 5%
California: #33,102 of 386,348 inventorsTop 9%
Overall (All Time): #245,716 of 4,157,543Top 6%
18 Patents All Time
Ryan Dellinger has been granted 18 US patents while listed as an inventor at Chromadex. The first was granted in 2014 and the most recent in October 2025. Ryan Dellinger ranks #245,716 of 4,157,543 US inventors in our database (top 5.9%). Patent records list Ryan Dellinger in Azusa, CA, US.

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
12433908 Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development Troy Rhonemus, Mark A. Morris, Dietrich Conze, Amy Boileau 2025-10-07
12350283 Methods and compositions for treating motor neuron diseases José María Estrela Arigüel, María Elena OBRADOR PLA, Rosario Salvador 2025-07-08
12128060 Nicotinamide riboside for use in treating or preventing liver damage Santiago Roel Santos, Eric Marcotulli, Daniel A. Alminana, Mark A. Morris, Leonard Pershing Guarente 2024-10-29
12043616 Crystalline forms of nicotinamide riboside chloride Eric Marcotulli, Dan Alminana, Mark A. Morris 2024-07-23
11730751 Treating and preventing motor neuron diseases using nicotinamide riboside José María Estrela Arigüel, José Enrique De La Rubia Orti 2023-08-22
11629163 Methods of synthesizing nicotinamide riboside Eric Marcotulli, Dan Alminana, Mark A. Morris, Rajesh Thamatam 2023-04-18
11524022 Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development Troy Rhonemus, Mark A. Morris, Dietrich Conze, Amy Boileau 2022-12-13
11414407 Crystalline forms of nicotinamide riboside chloride Eric Marcotulli, Dan Alminana, Mark A. Morris 2022-08-16
11389468 Nicotinamide riboside for use in treating or preventing liver damage Santiago Roel Santos, Eric Marcotulli, Daniel A. Alminana, Mark A. Morris, Leonard Pershing Guarente 2022-07-19
11129843 Treating and preventing kidney damage Eric Marcotulli, Daniel A. Alminana, Leonard Pershing Guarente, Mark A. Morris 2021-09-28
10934322 B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Troy Rhonemus +2 more 2021-03-02
10857172 Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development Troy Rhonemus, Mark A. Morris, Dietrich Conze, Amy Boileau 2020-12-08
10280190 Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions Marie Eugenie Migaud, Philip Redpath, Troy Rhonemus, Richard Cunningham 2019-05-07
10183036 Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors Troy Rhonemus, Mark A. Morris, Aron Erickson, Hadi Casser, Marie Eugenie Migaud 2019-01-22
10039725 Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene Jeremy Bartos 2018-08-07
10000520 B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Troy Rhonemus +2 more 2018-06-19
9980924 Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin Frank L. Meyskens, Jr. 2018-05-29
8841350 Method for inducing UDP-glucuronosyltransferase activity using pterostilbene Jeremy Bartos 2014-09-23